申请人:Tehim Ashok
公开号:US20080287484A1
公开(公告)日:2008-11-20
A pharmaceutical composition comprising a compound of Formula I
wherein R
1
is selected from, inter alia, alkyl, aryl-loweralkyl, heterocycle-loweralkyl, loweralkyl-carbonate; optionally substituted amino; benzimidaz-2-yl; optionally substituted phenyl; loweralkyl-(R
5
)(R
6
) wherein one of R
5
and R
6
is selected from H and the other is selected from carboxy, carboxy-loweralkyl and loweralkoxycarbonyl; NHCH
2
CH
2
OX wherein X represents an in vivo hydrolyzable ester; and R
2
and R
3
are independently selected from H, NO
2
, halo, di(loweralkyl)amino, cyano, C(O)OH, phenyl-S—, loweralkyl, and Z(O)OR
7
wherein Z is selected from C and S and R
7
is selected from H, loweralkylamino and arylamino; or pharmaceutically acceptable salts or certain in vivo hydrolyzable esters or amides thereof, in an amount effective to inhibit neurotrophin-mediated activity, and a suitable carrier, is described.
The compositions are useful to inhibit undesirable neurotrophin-mediated activity such as the neurite outgrowth that occurs in some neurodegenerative disease states.